ProfileGDS5822 / ILMN_2690214
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 33% 53% 28% 23% 35% 57% 60% 18% 34% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.333
GSM1276600PDAC Late Ablation Control 225.853
GSM1276601PDAC Late Ablation Control 39.428
GSM1276602PDAC Late Ablation 11223
GSM1276603PDAC Late Ablation 216.835
GSM1276604PDAC Late Ablation 329.457
GSM1303940PDAC Late Ablation_anti-CTLA4 128.460
GSM1303941PDAC Late Ablation_anti-CTLA4 210.118
GSM1303942PDAC Late Ablation_anti-CTLA4 316.334